GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Penumbra Inc (NYSE:PEN) » Definitions » Price-to-Operating-Cash-Flow
中文

Penumbra (Penumbra) Price-to-Operating-Cash-Flow : 83.13 (As of Apr. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Penumbra Price-to-Operating-Cash-Flow?

As of today (2024-04-25), Penumbra's share price is $206.15. Penumbra's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.48. Hence, Penumbra's Price-to-Operating-Cash-Flow Ratio for today is 83.13.

The historical rank and industry rank for Penumbra's Price-to-Operating-Cash-Flow or its related term are showing as below:

PEN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 81.01   Med: 261.79   Max: 1250
Current: 81.81

During the past 12 years, Penumbra's highest Price-to-Operating-Cash-Flow Ratio was 1250.00. The lowest was 81.01. And the median was 261.79.

PEN's Price-to-Operating-Cash-Flow is ranked worse than
90.87% of 438 companies
in the Medical Devices & Instruments industry
Industry Median: 20.79 vs PEN: 81.81

Penumbra's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.92. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.48.

During the past 12 years, Penumbra's highest 3-Year average Operating Cash Flow per Share Growth Rate was -32.00% per year. The lowest was -40.20% per year. And the median was -36.10% per year.


Penumbra Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Penumbra's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Penumbra Price-to-Operating-Cash-Flow Chart

Penumbra Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 223.50 - 1,144.70 - 101.35

Penumbra Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 736.75 151.86 101.35

Competitive Comparison of Penumbra's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Penumbra's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Penumbra's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Penumbra's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Penumbra's Price-to-Operating-Cash-Flow falls into.



Penumbra Price-to-Operating-Cash-Flow Calculation

Penumbra's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=206.15/2.48
=83.13

Penumbra's Share Price of today is $206.15.
Penumbra's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.48.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Penumbra Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Penumbra's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Penumbra (Penumbra) Business Description

Traded in Other Exchanges
Address
One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Executives
Harpreet Grewal director C/O VISTAPRINT USA, INCORPORATED, 100 HAYDEN AVE., LEXINGTON MA 02050
Surbhi Sarna director ONE PENUMBRA PLACE, ALAMEDA CA 94502
Johanna Roberts officer: EVP, Gen. Counsel & Secretary PENUMBRA, INC., ONE PENUMBRA PLACE, ALAMEDA CA 94502
Bridget O'rourke director ONE PENUMBRA PLACE, ALAMEDA CA 94502
Adam Elsesser director, officer: Chairman, CEO and President 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Don W. Kassing director 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Thomas Wilder director 2 MUSICK, IRVINE CA 92618
Arani Bose director, officer: Chief Innovator 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Lynn Rothman officer: EVP and Chief Business Officer 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
James Robert Pray officer: President, International 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Sridhar Kosaraju officer: CFO and Head of Strategy 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502
Maggie Yuen officer: Chief Financial Officer ONE PENUMBRA PLACE, ALAMEDA CA 94502
Lambert Shiu officer: Chief Accounting Officer ONE PENUMBRA PLACE, ALAMEDA CA 94502
Janet Leeds director ONE PENUMBRA PLACE, ALAMEDA CA 94502
Robert D. Evans officer: EVP, Gen. Counsel & Secretary ONE PENUMBRA PLACE, 1351 HARBOR BAY PARKWAY, ALAMEDA CA 94502